|
Hester Biosciences Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
1542.21 Cr.
|
P/BV
|
5.11
|
Book Value (Rs.)
|
354.81
|
|
52 Week High/Low (Rs.)
|
3379/1243
|
FV/ML
|
10/1
|
P/E(X)
|
56.11
|
|
Bookclosure
|
29/08/2024
|
EPS (Rs.)
|
32.31
|
Div Yield (%)
|
0.39
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 311.10 | 301.57 | 261.18 | 231.11 | 196.76 |
| Other Operating Revenues | 0.00 | 2.97 | 4.91 | 3.90 | 17.58 |
| Total Operating Revenues | 311.10 | 304.55 | 266.09 | 235.01 | 214.33 |
| | | | | | |
| Other Income | 3.92 | 10.64 | 15.15 | 13.74 | 4.68 |
| Total Revenue | 315.03 | 315.18 | 281.24 | 248.75 | 219.02 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 63.95 | 54.31 | 52.99 | 60.65 | 38.66 |
| Purchase Of Stock-In Trade | 17.60 | 32.82 | 29.75 | 12.62 | 7.97 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | 6.78 | 8.74 | -5.25 | -10.56 | 3.60 |
| Employee Benefit Expenses | 62.42 | 64.13 | 56.02 | 45.33 | 38.92 |
| Finance Costs | 12.70 | 19.78 | 9.32 | 4.06 | 6.60 |
| Depreciation And Amortisation Expenses | 16.80 | 17.17 | 20.70 | 16.58 | 13.31 |
| Other Expenses | 99.30 | 90.88 | 81.98 | 66.98 | 56.53 |
| Total Expenses | 279.56 | 287.84 | 245.50 | 195.67 | 165.59 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 35.47 | 27.34 | 35.75 | 53.08 | 53.42 |
| | | | | | |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | -3.32 |
| Profit/Loss Before Tax | 35.47 | 27.34 | 35.75 | 53.08 | 50.10 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 10.75 | 10.73 | 11.28 | 14.78 | 16.95 |
| Deferred Tax | 0.00 | 0.06 | 0.84 | -0.77 | -1.54 |
| Total Tax Expenses | 10.75 | 10.79 | 12.12 | 14.02 | 15.41 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 24.73 | 16.56 | 23.63 | 39.06 | 34.70 |
| | | | | | |
| Profit/Loss From Continuing Operations | 24.73 | 16.56 | 23.63 | 39.06 | 34.70 |
| | | | | | |
| Profit/Loss For The Period | 24.73 | 16.56 | 23.63 | 39.06 | 34.70 |
| | | | | | |
| Minority Interest | -1.34 | -2.28 | -1.41 | 0.00 | -0.27 |
| Share Of Profit/Loss Of Associates | 4.10 | 4.61 | 4.41 | 0.42 | 0.00 |
| Consolidated Profit/Loss After MI And Associates | 27.49 | 18.89 | 26.63 | 39.48 | 34.43 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 33.89 | 24.88 | 32.96 | 46.41 | 40.79 |
| Diluted EPS (Rs.) | 33.89 | 24.88 | 32.96 | 46.41 | 40.79 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 0.00 | 6.81 | 8.51 | 8.51 | 5.62 |
